Pharmacokinetic Study to Compare Itepekimab Exposure When Administered With an Autoinjector Versus Prefilled Syringe

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

March 8, 2022

Study Completion Date

March 8, 2022

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Itepekimab AI

Pharmaceutical form:Solution for injection; Route of administration: Subcutaneous AI

DRUG

Itepekimab PFS

Pharmaceutical form:Solution for injection; Route of administration: Subcutaneous PFS

Trial Locations (1)

Clinical Pharmacology of Miami Site Number : 8400001, Miami